Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Post by WalkOverTheStrton Feb 21, 2022 10:28am
274 Views
Post# 34447700

Emotions and retail

Emotions and retailNoticed that most of the Ventripoint message boards (including this one) have gone negative with many former longs or assumed longs stating they sold out.
Part of this change (assumed) is based off emotions of watching the stock price erode without any news of sales, large distributors and GE HC launch date.  Those points and a poorly executed call have many throwing in the towel.  

From a risk reward view I am going to hold for the following reasons:

- George on the recent call stated GE HC is still proceeding Q1 2022 as well as other distributors (Europe and NA) are moving fwd.
-  COVID is lifting which has impacted hospitals purchasing / sales efforts 
- VMS 4.0 is in process of being tested which if successful adds to the valuation (potentially 1-3 hundred million) 
- No requirement for capital 
- Guiance of 80-100 unit sales Q4 2022

For me to sell at a loss now when the GE HC rollout is still a go isnt practical. What i do not understand is for those that sold why are you still here? It appears to be out of bitterness and inability to let go / learn from it and move onward...

<< Previous
Bullboard Posts
Next >>